Would you do SRS for a patient who cannot receive gadolinium contrast and has a single brain metastasis on non-contrast MRI?
For patients with eGFR of < 30, there is a risk of irreversible nephrogenic systemic fibrosis with gadolinium. Would you prefer whole brain for these patients or SRS for the lesion noted on non-contrast MRI?
Answer from: Radiation Oncologist at Academic Institution
There is a reasonable concern that other small brain metastasis could be present without obtaining fine cut T1 imaging with gadolinium contrast. As long as the patient is otherwise a reasonable candidate for radiosurgery, and can return for follow up, I would feel comfortable going ahead with ...
Comments
Radiation Oncologist at Mount Sinai Medical Center Miami Risk of NSF is quite small, and depending on the c...
Answer from: Radiation Oncologist at Academic Institution
While the concern for smaller metastases going undetected remains, from a brain preservation point of view, we use GRE sequences and other means to detect what mets we can use SRS to. Regular follow up is key. Smaller mets are clinically inconsequential except in the setting of leptomeningeal diseas...
Risk of NSF is quite small, and depending on the c...